Home > Drug Search >
  • company_query: BiondVax
  •   > 
Drug Filter
Category:
chemistry (10) biology (24)
Status:
Approved (2) Withdrawn (1) BLA Filing (2) Phase Ⅲ (3) Phase Ⅱ (15) Phase Ⅰ (11)
Clinical Stage:
Pending (3) Active (23) Discontinued (5)
Bio-Type:
Gene therapy (4) CAR T cell therapy (2) Vaccine (7) Recombinant enzyme (2) Recombinant polypeptide (1) Recombinant cytokines (1) Whole antibody (2) Fusion protein (1)
Indication:
Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (1) Atopic dermatitis (1) Bladder cancer (2) Breast cancer (1) Cognitive disorders (1) Induced mydriasis (1) HBV infection (1) HIV infection (2) Influenza virus infection (1) Irritable bowel syndrome (IBS) (1) Rabies (1) Melanoma (1) Myocardial infarction (MI) (1) Osteoporosis (1) Ovarian cancer (1) Pancreatic cancer (2) Perennial allergic rhinitis (1) Pneumonia (1) Prostate cancer (2) Rheumatoid arthritis (RA) (1) Seasonal allergic rhinitis (1) Solid tumours (3) Leber's hereditary optic atrophy (1) Leber congenital amaurosis (1) Exanthema (1) Tuberculosis (2) Ulcerative colitis (1) Malignant pleural effusion (1) Age-related macular degeneration (AMD) (1) Pain (1) Facial Erythema of Rosacea (1) Hemophilia B (1) Esophageal adenocarcinoma (1) Glioblastoma (2) Glioma (1) Allergic asthma (1) Port wine stain (1) Spinal and bulbar muscular atrophy (1) Hypersensitivity (1)
Country:
Aprv. Year:
1995 (1) 2012 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top